NANO DIMENSIONS, INC.
11650 South State Street, Suite 240
Draper, Utah 84020
(801) 816-2533
FAX: (801) 816-2599
March 11, 2011
Mr. Ryan C. Milne
U.S. Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
Telephone (202) 551-3688
Re: Cancer Therapeutics, Inc.
Form 8-K Item 4.01
Filed January 19, 2011
File No. 000-52473
Dear Mr. Milne:
This letter is written pursuant to a filing of a current report on Form 8-K (“Report”) with the Securities and Exchange Commission (“Commission”) on January 19, 2011 by Nano Dimensions, Inc., f/k/a Cancer Therapeutics, Inc., (the “Company). This letter is also an acknowledgement of receipt of a letter from the Commission, dated February 4, 2011, concerning the Report.
Pursuant to our Report, the Company further acknowledges that:
· | The Company is responsible for the adequacy and accuracy of the disclosure in the Report; |
· | Staff comments or changes to disclosure in response to staff comments do not foreclose the Commission from taking any action with respect to the Report; and |
· | The Company may not assert staff comments as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States. |
Sincerely,
/s/ Chene C. Gardner
Chief Executive Officer